A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.

Some weight loss injections include liraglutide, semaglutide, and tirzepatide. Weight loss injections involve a person injecting medications under their skin over a long period to aid weight loss.

Semaglutide is probably the best known of the new GLP-1 agonists ... A month's supply of a 10mg maintenance dose is priced at around R4 600. Liraglutide is marketed by Novo Nordisk in three ...

Semaglutide is probably the best known of ... A month's supply of a 10mg maintenance dose is priced at around R4 600. Liraglutide is marketed by Novo Nordisk in three formulations: Saxenda ...